These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9878862

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M, Kamei J.
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [Abstract] [Full Text] [Related]

  • 3. Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
    Kamei J, Ohsawa M.
    Life Sci; 1997 Mar; 60(15):PL223-8. PubMed ID: 9096248
    [Abstract] [Full Text] [Related]

  • 4. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W, Sato T, Nakagawasai O, Yaoita F, Silberring J, Tadano T, Tan-No K.
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Tan-No K, Sato T, Shimoda M, Nakagawasai O, Niijima F, Kawamura S, Furuta S, Sato T, Satoh S, Silberring J, Terenius L, Tadano T.
    Neuropeptides; 2010 Jun; 44(3):279-83. PubMed ID: 20189644
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF, Brase DA, Loh HH.
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice.
    Bai YL, Chu QJ, Li J, Chen YY, Li WJ, Zhang Q.
    Eur J Pharmacol; 2012 Nov 05; 694(1-3):69-74. PubMed ID: 22960325
    [Abstract] [Full Text] [Related]

  • 15. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T, Hou Y, Cao W, Yan CX, Chen T, Li SB.
    Neurosci Lett; 2010 Jan 14; 468(3):348-52. PubMed ID: 19922770
    [Abstract] [Full Text] [Related]

  • 16. Implication of the signal transduction pathways in the enhancement of noradrenaline turnover induced by morphine withdrawal in the heart.
    Martínez MD, Milanés MV, Laorden ML.
    Eur J Pharmacol; 2003 Jun 20; 471(2):113-9. PubMed ID: 12818698
    [Abstract] [Full Text] [Related]

  • 17. Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice.
    Cheaha D, Reakkamnuan C, Nukitram J, Chittrakarn S, Phukpattaranont P, Keawpradub N, Kumarnsit E.
    J Ethnopharmacol; 2017 Aug 17; 208():129-137. PubMed ID: 28687506
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Naloxone-precipitated withdrawal reveals sensitization to neurotransmitters in morphine tolerant/dependent rats.
    Schulz R, Herz A.
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug 17; 299(1):95-9. PubMed ID: 20584
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.